Skip to content
POM-V Prescription Required

Suvaxyn Circo+MH RTU Emulsion for Injection for Pigs

Active ingredients: Mycoplasma hyopneumoniae, recombinant Porcine Circovirus type 1 expressing the Porcine circovirus type 2 ORF2 protein

Form

Injection

Species

Pigs

Manufacturer

Zoetis UK Limited

VMD MA No.

42058/5072

What it's used for

For active immunisation of pigs from 3 weeks of age against porcine circovirus type 2 (PCV2) to reduce viral load in blood and lymphoid tissues and fecal s...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Mycoplasma hyopneumoniae + r...

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Suvaxyn Circo+MH RTU Emulsion for Injection for Pigs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For active immunisation of pigs from 3 weeks of age against porcine circovirus type 2
(PCV2) to reduce viral load in blood and lymphoid tissues and fecal shedding caused
by infection with PCV2.
For active immunization of pigs from the age of 3 weeks against Mycoplasma
hyopneumoniae to reduce lung lesions caused by infection with M. hyopneumoniae.
Onset of immunity: 3 weeks.
Duration of immunity: 23 weeks.
None.
Pigs (for fattening):
Very common
(>1 animal / 10 animals treated):
Elevated temperature
Injection site inflammation
,
Injection site pain
, injection site reddening
,
injection site swelling
Uncommon
(1 to 10 animals / 1,000
animals treated):
Hypersensitivity

reactions (e.g. depression,
diarrhoea or vomiting)
Very rare
(1 animal / 10,000 animals
treated, including isolated
reports):
Anaphylaxis
Revised: June 2024
AN: 01093/2023
Transient; observed during the first 24 hours after vaccination. On average 1° C but
may exceed 2° C in individual pigs This resolves spontaneously within 48 hours
without treatment.
Post-mortem examination of the injection site, performed 4 weeks after the
administration of a repeated single dose of the vaccine very commonly revealed a
mild lymphocytic-granulomatous inflammatory response.
The area of local tissue reaction is in general below 2 cm in diameter and may last to
up 2 days.
Normally resolve without treatment.
In case of such reactions, appropriate treatment is recommended.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.
Vaccinate only healthy animals.

Special precautions for use in animals
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment
Not applicable.
Other precautions
Not applicable.
No information is available on the safety and efficacy of this vaccine when used
with any other veterinary medicinal product. A decision to use this vaccine before
or after any other veterinary medicinal product therefore needs to be made on a
case by case basis.
Store and transport refrigerated (2 °C – 8 °C).
Do not freeze.
Protect from light.
Zero days.
5. IMMUNOLOGICAL PROPERTIES
Pharmacotherapeutic group: immunologicals for Suidae, inactivated viral and
inactivated bacterial vaccines for pigs.
ATCvet code: QI09AL08
The vaccine contains an inactivated recombinant chimeric porcine circovirus type 1
containing the porcine circovirus type 2 ORF2 protein. The vaccine also contains
inactivated Mycoplasma hyopneumoniae. It is intended to stimulate active immunity
against PCV2 and Mycoplasma hyopneumoniae in pigs.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.